← Open Payments lookup

AMANDA BIERMAN: Open Payments

NPI 1285199422 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$687 in 29 payments from 15 companies in 2025. Trend: 2023 $729 · 2024 $413 · 2025 $687

Food & beverage: $687
CompanyPaymentsAmount
Travere Therapeutics, Inc.5$163
Novartis Pharmaceuticals Corporation3$83
Alexion Pharmaceuticals, Inc.3$79
Bayer Healthcare Pharmaceuticals Inc.4$74
Fresenius USA Marketing, Inc.3$62
AstraZeneca Pharmaceuticals LP2$30
Vifor Pharma, Inc.1$27
Novo Nordisk Inc1$26
Calliditas Therapeutics US Inc.1$24
Genentech USA, Inc.1$22

Products named: ULTOMIRIS, Kerendia, VELPHORO, Fabhalta, FARXIGA, Veltassa, Ozempic, Vanrafia.

Industry payments across KY — which companies pay providers there.